Live Breaking News & Updates on Pharmatech Inc

Stay updated with breaking news from Pharmatech inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Quest PharmaTech (CVE:QPT) Hits New 1-Year Low at $0.02

Quest PharmaTech Inc. (CVE:QPT – Get Free Report)’s share price reached a new 52-week low during trading on Wednesday . The company traded as low as C$0.02 and last traded at C$0.02, with a volume of 7000 shares. The stock had previously closed at C$0.03. Quest PharmaTech Price Performance The company has a quick ratio […] ....

Quest Pharmatech Inc , Quest Pharmatech Company Profile , Quest Pharmatech , Get Free Report , Pharmatech Inc , Quest Pharmatech Daily , Cve Qpt ,

Oregovomab Phase III Clinical Study fails futility analysis; Data Safety Monitoring Board Recommends Overall Survival Follow Up for Potential Late Immune Effects and Clinical Benefits

Oregovomab Phase III Clinical Study fails futility analysis; Data Safety Monitoring Board Recommends Overall Survival Follow Up for Potential Late Immune Effects and Clinical Benefits
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United States , South Korea , Oncoquest Inc , Venture Exchange , Canariabiom Co , Regulation Services Provider , Industrial Co Ltd , Companya Canadian , Canariabio Inc , Bio Inc , Quest Pharmatech Inc , University Of Nebraska , Potential Late Immune Effects , Quest Pharmatech , Ovarian Cancer , Data Safety Monitoring Board , Pharmatech Inc , Greater China ,

Quest PharmaTech (CVE:QPT) Hits New 52-Week Low at $0.05

Quest PharmaTech Inc. (CVE:QPT – Get Free Report) reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as C$0.05 and last traded at C$0.05, with a volume of 81844 shares trading hands. The stock had previously closed at C$0.05. Quest PharmaTech Price Performance The company has a debt-to-equity […] ....

Quest Pharmatech Inc , Quest Pharmatech , Get Free Report , Pharmatech Inc , Quest Pharmatech Daily , Cve Qpt ,

YDS Pharmatech, Inc. CEO to Highlight AI Advancements in Designing New Drug Modalities at Bio Investor Forum on October 17th

YDS Pharmatech, Inc. CEO to Highlight AI Advancements in Designing New Drug Modalities at Bio Investor Forum on October 17th
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Joshua Elkington , Xing Che , Pharmatech Inc , Bio Investor Forum , Bio Investor , Scientific Advisor , Nature Chemical Biology ,